The p53 targets mdm2 and Fas are not required as mediators of apoptosis in vivo

被引:0
|
作者
Valerie Reinke
Guillermina Lozano
机构
[1] The University of Texas MD Anderson Cancer Center,Department of Molecular Genetics
来源
Oncogene | 1997年 / 15卷
关键词
apoptosis; p53; targets; ionizing radiation; mice;
D O I
暂无
中图分类号
学科分类号
摘要
The tumor suppressor p53 can exert its anti-oncogenic activity in part by inducing apoptosis in cells that have sustained damage to their DNA. It is likely that p53 activates the transcription of target genes that mediate this response. Known p53 targets with potential roles in cell cycle control and apoptosis induction include: p21WAF1/CIP1, mdm2, cyclin G, bax and Fas. We examined the p53 pathway in the thymus of the mouse after irradiation. FACS analysis demonstrated that the thymocytes of mice with wild-type p53, but not those lacking p53, underwent apoptosis after irradiation. Expression analysis of the target genes revealed that all tested genes underwent p53-dependent induction, although the extent and timing varied. The target genes implicated in cell cycle (p21, mdm2 and cyclin G) were induced 2 h after irradiation, in contrast to targets with a possible role in apoptosis (bax and Fas), which were induced at 4 h. This analysis is the first demonstration that Fas is a p53-responsive gene in vivo. Since p21 and bax expression are not required for p53-dependent apoptosis, we tested whether other target genes affected apoptosis in vivo. We discovered that mdm2 has no role in preventing apoptosis independently of p53 inactivation, and that Fas, like p21 and bax, is not necessary for p53-mediated induction of apoptosis. Therefore, no p53 target identified and tested to date is singly responsible for p53-dependent apoptosis in response to DNA damage in vivo.
引用
收藏
页码:1527 / 1534
页数:7
相关论文
共 50 条
  • [1] The p53 targets mdm2 and Fas are not required as mediators of apoptosis in vivo
    Reinke, V
    Lozano, G
    ONCOGENE, 1997, 15 (13) : 1527 - 1534
  • [2] The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo
    Huang, Lei
    Yan, Zheng
    Liao, Xiaodong
    Li, Yuan
    Yang, Jie
    Wang, Zhu-Gang
    Zuo, Yong
    Kawai, Hidehiko
    Shadfan, Miriam
    Ganapathy, Suthakar
    Yuan, Zhi-Min
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (29) : 12001 - 12006
  • [3] Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo
    Ringshausen, Ingo
    O'Shea, Cloclagh C.
    Finch, Andrew J.
    Swigart, Lamorna Brown
    Evan, Gerard I.
    CANCER CELL, 2006, 10 (06) : 501 - 514
  • [4] Oligomerization is required for p53 to be efficiently ubiquitinated by MDM2
    Maki, CG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (23) : 16531 - 16535
  • [6] Mdm2 association with p53 targets its ubiquitination
    Fuchs, SY
    Adler, V
    Buschmann, T
    Wu, XW
    Ronai, Z
    ONCOGENE, 1998, 17 (19) : 2543 - 2547
  • [7] Inactivation of Mdm2 restores apoptosis proficiency of cooperativity mutant p53 in vivo
    Klimovich, Boris
    Stiewe, Thorsten
    Timofeev, Oleg
    CELL CYCLE, 2020, 19 (01) : 109 - 123
  • [8] Mdm2 association with p53 targets its ubiquitination
    Serge Y Fuchs
    Victor Adler
    Thomas Buschmann
    Xiangwei Wu
    Ze'ev Ronai
    Oncogene, 1998, 17 : 2543 - 2547
  • [9] The loss of mdm2 induces p53 mediated apoptosis
    de Rozieres, S
    Maya, R
    Oren, M
    Lozano, G
    ONCOGENE, 2000, 19 (13) : 1691 - 1697
  • [10] The loss of mdm2 induces p53 mediated apoptosis
    Sohela de Rozieres
    Ruth Maya
    Moshe Oren
    Guillermina Lozano
    Oncogene, 2000, 19 : 1691 - 1697